The invention relates generally to an accommodating intraocular lens device and, more particularly, to an accommodating intraocular lens device configured for implantation in a lens capsule of a subject's eye.
Surgical procedures on the eye have been on the rise as technological advances permit for sophisticated interventions to address a wide variety of ophthalmic conditions. Patient acceptance has increased over the last twenty years as such procedures have proven to be generally safe and to produce results that significantly improve patient quality of life.
Cataract surgery remains one of the most common surgical procedures, with over 16 million cataract procedures being performed worldwide. It is expected that this number will continue to increase as average life expectancies continue to rise. Cataracts are typically treated by removing the crystalline lens from the eye and implanting an intraocular lens (“IOL”) in its place. As conventional IOL devices are primarily focused for distance visions, they fail to correct for presbyopia and reading glasses are still required. Thus, while patients who undergo a standard IOL implantation no longer experience clouding from cataracts, they are unable to accommodate, or change focus from near to far, from far to near, and to distances in between.
Surgeries to correct refractive errors of the eye have also become extremely common, of which LASIK enjoys substantial popularity with over 700,000 procedures being performed per year. Given the high prevalence of refractive errors and the relative safety and effectiveness of this procedure, more and more people are expected to turn to LASIK or other surgical procedures over conventional eyeglasses or contact lens. Despite the success of LASIK in treating myopia, there remains an unmet need for an effective surgical intervention to correct for presbyopia, which cannot be treated by conventional LASIK procedures.
As nearly every cataract patient also suffers from presbyopia, there is convergence of market demands for the treatment of both these conditions. While there is a general acceptance among physicians and patients of having implantable intraocular lens in the treatment of cataracts, similar procedures to correct for presbyopia represent only 5% of the U.S. cataract market. There is therefore a need to address both ophthalmic cataracts and/or presbyopia in the growing aging population.
The two-part accommodating IOL devices disclosed herein provides for a number of advantages owing to its separate two-part construction. Implantation of the IOL device requires a significantly reduced incision size, as the two parts of the IOL device are implanted separately and thus significantly reducing the delivery profile for implantation. The reduced incision size provides for a number of advantages, including obviating the need for anesthesia and sutures to close the incision site and improved surgical outcomes.
Additionally, greater control is afforded with respect to adjusting the sizing and the power of the IOL during surgery. Implanting the primary lens into the lens capsule will provide the physician an impression as to the size of the patient's lens capsule and will thus help verify the correct size of the power changing lens that will subsequently be implanted.
In one embodiment, a two-part accommodating intraocular lens (IOL) device for implantation in a capsular bag of a patient's eye is described. The IOL device comprises a primary lens assembly and a power changing lens assembly. The primary lens assembly comprises a fixed lens and a centration member disposed peripherally of the fixed lens. The centration member has a circumferential distal edge and a first coupling surface adjacent the circumferential distal edge. The power changing lens comprises an enclosed and fluid- or gel-filled lens cavity and a haptic system disposed peripherally of the lens cavity. The haptic system has a peripheral engaging edge configured to contact the capsular bag and a second coupling surface facing the first coupling surface and located adjacent the peripheral engaging edge. The first and second coupling surfaces are in sliding contact with one another to permit movement of the power changing lens relative to the primary lens assembly. The first and second coupling surfaces maintain a spaced relationship between the fixed lens and the lens cavity when the power changing lens is radially compressed.
In accordance with a first aspect, a diameter d1 of the power changing lens is greater than a diameter d2 of the primary lens assembly in the absence of radial compression.
In accordance with a second aspect, the fixed lens does not change shape or curvature during accommodation.
In accordance with a third aspect, the lens cavity changes both shape and curvature during accommodation.
In accordance with a fourth aspect, the fixed lens and the lens cavity are positive power lenses.
In accordance with a fifth aspect, the fluid- or gel-filled lens cavity is a biconvex lens.
In accordance with a sixth aspect, the fixed lens assembly comprises a squared edge located circumferentially around the fixed lens outside of the optical zone.
In accordance with a seventh aspect, the facing surfaces of the centration member and the haptic system each comprise one of a complementary and interlocking pair, the interlocking pair being disposed circumferentially around the fixed lens and the power changing lens, respectively.
In accordance with an eighth aspect, the peripheral engaging edge is thicker than the circumferential distal edge.
In accordance with a ninth aspect, the thickness ratio of the circumferential distal edge to the peripheral engaging edge is in the range of about 1:5 to about 1:2.
In accordance with a tenth aspect, the primary lens assembly has a higher Young's modulus of elasticity than the power changing lens.
In accordance with an eleventh aspect, at least one of the centration member and the haptic system comprises a plurality of openings.
In accordance with a twelfth aspect, the power changing lens is comprised of two opposing surfaces which are displaced away from each other upon the application of a radial force along a peripheral edge, the two opposing surfaces having central and peripheral regions and a gradually increasing thickness profile from the peripheral to the central regions.
In another embodiment, a two-part accommodating intraocular lens (IOL) device for implantation in a capsular bag of a patient's eye is described. The IOL comprises a primary lens assembly and a power changing lens assembly. The primary lens assembly comprises a fixed lens and a centration member disposed peripherally of the fixed lens. The centration member has a radially-compressible peripheral edge having an outer circumferential surface configured to engage the capsular bag of the patient's eye and an inner circumferential surface spaced radially inward of the outer circumferential surface. The power changing lens comprises an enclosed and fluid- or gel-filled lens cavity and a haptic system disposed peripherally of the lens cavity. The haptic system has a circumferential edge configured to engage the inner circumferential surface. Radial compression applied to the outer circumferential surface causes at least one of an increase in curvature and a decrease in diameter of the lens cavity and radial compression applied to the outer circumferential surface does not cause an increase in curvature or a decrease in diameter of the fixed lens.
In accordance with a first aspect, the centration member further comprises circumferential hinges between the fixed lens and the peripheral edge, the circumferential hinges being disposed on opposing sides of the centration member.
In accordance with a second aspect, the centration member further comprises a single circumferential hinge between the fixed lens and the peripheral edge.
In accordance with a third aspect, the circumferential hinge is disposed on an inner surface of the haptic facing the power changing lens.
In accordance with a fourth aspect, the circumferential edge of the haptic system and the inner circumferential surface of the peripheral edge have complementary rounded surfaces and radial compression applied to the outer circumferential surface cause the peripheral edge to tilt radially inwardly about the circumferential hinge.
In accordance with a fifth aspect, the power changing lens is entirely contained within the peripheral edge of the primary lens assembly.
In accordance with a sixth aspect, the power changing lens further comprises a circumferential lip disposed radially inwardly of the inner surface of the circumferential edge.
In accordance with an seventh aspect, the power changing lens is comprised of two opposing surfaces which are displaced away from each other upon the application of a radial force along a peripheral edge, the two opposing surfaces having central and peripheral regions, wherein the region has a thickness that is at least two times, preferably at least three times, and most preferably at least 4 times greater than a thickness of the peripheral region.
In a further embodiment, a method for implanting a two-part IOL device in a capsular bag of a patient's eye is described. The method comprises first inserting and positioning a primary lens assembly in the capsular bag of the patient's eye through an incision located in the cornea, the primary lens having a fixed lens and a centration member disposed peripherally of the fixed lens. The next step comprises inserting and positioning a power changing lens in the capsular bag of the patient's eye anteriorly of the primary lens assembly, the power changing lens comprising an enclosed and fluid- or gel-filled lens cavity and a haptic system disposed peripherally of the lens cavity, the haptic system having a peripheral engaging edge configured to contact the capsular bag. The primary lens assembly is in contact with a posterior portion of the capsular bag and the power changing lens is in contact with the anterior portion of the capsular bag after implantation. The fixed lens and the lens cavity are centered about an optical axis.
In accordance with a first aspect, the incision is less than 5 mm, preferably less than 4 mm, and most preferably less than 3 mm.
In accordance with a second aspect, both of the inserting steps are performed through the incision.
In accordance with a third aspect, the method further comprises injecting a viscoelastic material before the inserting and positioning of the power changing lens.
Other objects, features and advantages of the described preferred embodiments will become apparent to those skilled in the art from the following detailed description. It is to be understood, however, that the detailed description and specific examples, while indicating preferred embodiments of the present invention, are given by way of illustration and not limitation. Many changes and modifications within the scope of the present invention may be made without departing from the spirit thereof, and the invention includes all such modifications.
Illustrative embodiments of the present disclosure are described herein with reference to the accompanying drawings, in which:
Like numerals refer to like parts throughout the several views of the drawings.
Specific, non-limiting embodiments of the present invention will now be described with reference to the drawings. It should be understood that such embodiments are by way of example and are merely illustrative of but a small number of embodiments within the scope of the present invention. Various changes and modifications obvious to one skilled in the art to which the present invention pertains are deemed to be within the spirit, scope and contemplation of the present invention as further defined in the appended claims.
The power changing lens 110 is depicted as comprising a fluid- or gel-filled lens chamber 112 and a haptic system 114 disposed peripherally of the fluid- or gel-filled lens chamber 112. The haptic system 114 comprises a peripheral engaging edge 116 that is configured to engage the capsular bag of the patient's eye, generally at a location where it is attached via zonules to the ciliary muscles. A plurality of through holes 115 may be disposed along the circumference of the haptic system 114 to reduce material bulk and thus the delivery profile of the power changing lens 110.
The primary lens 120 is depicted as comprising a fixed-power lens 122 and a plurality of centration members 124 disposed symmetrically about the fixed-power lens. The centration member 124 comprises a distal edge 126 and through holes 125 to reduce the resistance to radial compression exerted by the capsular bag.
The presence of the holes 115 in the power lens 110 allows the manipulation of both the power lens 110 and the primary lens 120 underneath it. The holes 115 also help reduce the delivery profile of the power lens 110 and permits both the power lens 110 and the primary lens 120 to be manipulated to center it in the capsular bag during implantation. The presence of holes 115 may also reduce the rigidity of the power lens. Similarly, the primary lens 120 also has holes 125 that permit manipulation and reduce delivery profile. The holes 125 of the primary lens 120 are additionally shaped so as to reduce the likelihood of grabbing the power changing lens 110 when the power changing lens 110 is implanted into the capsular bag of the patient's eye after the primary lens 120 has already been implanted.
The power changing lens 110 and the primary lens 120 is configured to be in sliding contact with one another, while maintaining a separation between the fluid- or gel-filled lens chamber 112 and the fixed-power lens 122. In one embodiment, this distance is maintained by angling either one or both of the haptic system 114 and the centration member 124 towards one another. As shown in
The power changing lens 110 is sized and shaped to take on and respond to the radially-inward forces which are applied along the peripheral edge 116 of the lens 110. In contrast, the primary lens 120 does not participate in providing an accommodative response and thus is sized and shaped so as to avoid interfering or resisting the radial compressive forces that are applied to the power changing lens 110. This may be accomplished by controlling the relative diameters and thicknesses of the power changing lens 110 and the primary lens 120 to maximize the extent to which the radial compressive forces are applied onto the power changing lens 110 and to minimize the extent to which these forces are applied onto the primary lens 120.
In a preferred embodiment, as depicted in
In one preferred embodiment, at least the opposing sides or walls of the lens chamber 112 is made of a material of sufficient mechanical strength to withstand physical manipulation during implantation, but is of sufficiently low Young's modulus so as to minimize its resistance to deformation. In a preferred embodiment, the opposing sides of the lens chamber 112 is made of a polymer having a Young's modulus of 100 psi or less, preferably 75 psi or less, and most preferably 50 psi or less. In one preferred embodiment, the remaining portions of the IOL 100 has a Young's modulus that is greater than the Young's modulus of the lens chamber 112. The walls of the lens chamber 112 may be a polymer, preferably a silicone polymer and more preferably a phenyl siloxane, such as a vinyl-terminated phenyl siloxane or a vinyl-terminated diphenyl siloxane. In order to impart sufficient mechanical strength, the polymer may be crosslinked, reinforced with fillers, or both. The fillers may be a resin or silica that have been functionalized to react with the polymer.
The walls of the lens chamber 112 define an enclosed cavity that is filled with a fluid or gel having specific physical and chemical characteristics to enhance the range of refractive power provided by the IOL during accommodation. The fluid or gel is selected such that it cooperates with the power changing lens 110 in providing a sufficient range of accommodation of up to at least 3 diopters, preferably up to at least 5 diopters, preferably up to at least 10 diopters and most preferably up to at least 15 diopters. In a preferred embodiment, the enclosed cavity is filled with the fluid or gel before implantation of the IOL 100 into the capsular bag 40 of the eye and, in a more preferred embodiment, the cavity is filled with the fluid or gel in the manufacture of the IOL 100.
In accordance with one embodiment, fluid (213, 313, 413, 513) may be a polyphenyl ether (“PPE”), as described in U.S. Pat. No. 7,256,943, entitled “Variable Focus Liquid-Filled Lens Using Polyphenyl Ethers” to Teledyne Licensing, LLC, the entire contents of which are incorporated herein by reference as if set forth fully herein.
In accordance with another embodiment, the fluid (213, 313, 413, 513) may be a fluorinated polyphenyl ether (“FPPE”). FPPE has the unique advantage of providing tunability of the refractive index while being a chemically inert, biocompatible fluid with dispersion properties. The tunability is provided by the increasing or decreasing the phenyl and fluoro content of the polymer. Increasing the phenyl content will effectively increase the refractive index of the FPPE, whereas increasing the fluoro content will decrease the refractive index of the FPPE while decreasing the permeability of the FPPE fluid through the walls of the lens chamber 112.
In another preferred embodiment, the enclosed cavity defined by walls of the lens chamber 112 is filled with a gel (213, 313, 413, 513). The gel (213, 313, 413, 513) preferably has a refractive index of at least 1.46, 1.47, 1.48, or 1.49. The gel may also preferably have a Young's modulus of 20 psi or less, 10 psi or less, 4 psi or less, 1 psi or less, 0.5 psi or less, 0.25 psi or less and 0.01 psi or less. In a preferred embodiment, the gel (213, 313, 413, 513) is a crosslinked polymer, preferably a crosslinked silicone polymer, and more preferably a crosslinked phenyl siloxane polymer, such as a vinyl-terminated phenyl siloxane polymer or a vinyl-terminated diphenyl siloxane polymer. Other optically clear polymer liquids or gels, in addition to siloxane polymers, may be used to fill the enclosed cavity and such polymers may be branched, unbranched, crosslinked or uncrosslinked or any combination of the foregoing.
A gel has the advantages of being extended in molecular weight from being crosslinked, more self-adherent and also adherent to the walls or opposing sides lens chamber 112 than most liquids. This makes a gel less likely to leak through the walls of the power changing lens. In order to obtain the combination of accommodative power with relatively small deformations in the curvature of the power changing lens, the gel (213, 313, 413, 513) is selected so as to have a high refractive index while being made of an optically clear material that is characterized as having a low Young's modulus. Thus, in a preferred embodiment, the gel has a refractive index of 1.46 or greater, preferably 1.47 or greater, 1.48 or greater and most preferably 1.49 or greater. At the same time, the gel preferably has a Young's modulus of 10 psi or less, preferably 5 psi or less, and more preferably 1 psi or less. In a particularly preferred embodiment, the gel has a Young's modulus of 0.5 psi or less, preferably 0.25 psi or less, and most preferably 0.01 psi or less. It is understood that at lower Young's modulus, the gel will present less resistance to deformation and thus the greater the deformation of the power changing lens 110 for a given unit of applied force.
In particularly preferred embodiment, the gel is a vinyl-terminated phenyl siloxane that is produced based on one of the four formulas provided as follows:
Formula 1:
Formula 2:
Formula 3:
Formula 4:
The walls of the lens chamber and the fluid or gel contained within the cavity is preferably selected so as to prevent or reduce the likelihood of the fluid or gel migrating outside of the lens chamber. Thus, in a preferred embodiment, one or both of the power changing lens and the fluid or gel (213, 313, 413, 513) is/are selected from biocompatible materials that optimize the resistance to permeability of the fluid or gel across the power changing lens.
One method of decreasing the permeability of the gel contained inside the cavity and across the power changing lens is to provide a gel that is cross-linked. The degree of cross-linking, however, must be selected and controlled such that, on the one hand, the power changing lens and the gel have a sufficiently low Young's modulus to minimize the resistance of the power changing lens to deformation and, on the other hand, to minimize the permeation of the gel across the power changing lens. Thus, in a preferred embodiment, longer chain polymers that are lightly cross-linked, such as those used for silicone gels, starting with monomers having molecular weights that are greater than 35,000 daltons, preferably greater than 50,000 daltons and, most preferably, at least 70,000 daltons are desired.
In another preferred embodiment, a gel is used having low permeability extractables. Such gels may be formulated by using long chain polymers that are branched.
In a preferred embodiment, one or both of the lens chamber walls and the gel may be made of homo- or co-polymers of phenyl-substituted silicones.
For the lens chamber walls, the crosslinked homo- or co-polymers preferably have a diphenyl content of 5-25 mol %, preferably 10-20 mol % and more preferably 15-18 mol %. Alternatively, for the lens chamber walls, the homo- or co-polymers preferably have a phenyl content of 10-50 mol %, preferably 20-40 mol %, and more preferably 30-36 mol %.
For the gel, the homo- or co-polymers preferably have a diphenyl content of 10-35 mol %, preferably 15-30 mol % and more preferably 20-25 mol %. Alternatively, for the gel, the homo- or co-polymers preferably have a phenyl content of 20-70 mol %, preferably 30-60 mol % and more preferably 40-50 mol %.
In a particularly preferred embodiment, the walls of the lens chamber are made of a crosslinked phenyl siloxane having a diphenyl content of about 15-18 mol % or a phenyl content of about 30-36 mol % and the gel is made of a phenyl siloxane having a diphenyl content of about 20-25 mol % or a phenyl content of about 40-50 mol %. The walls of the lens chamber walls are understood to be more crosslinked than the gel.
In a particularly preferred embodiment, the lens chamber walls are made of a vinyl-terminated phenyl siloxane, most preferably a crosslinked vinyl-terminated phenyl siloxane. Reinforcing agents, such as silica, may also be included in a range of 10-70 mol %, preferably 20-60 mol % and most preferably 30-50 mol %.
The walls of the lens chamber and the fluid or gel contained within the cavity is also preferably selected so as to increase the range of accommodative power that is provided by the lens chamber. In one preferred embodiment, the walls of the lens chamber are made of a material having a lower refractive index than the fluid or gel contained in the enclosed cavity. In one preferred embodiment, the refractive index of the walls of the lens chamber is 1.38 and the refractive index of the gel or fluid contained therein is 1.49.
The differential refractive indices provided by the lens chamber walls and the gel or liquid contained within the lens chamber may be provided by differences in the materials or the composition of the materials used for the lens chamber walls and the gel or liquid.
In one embodiment, both the lens chamber walls and the gel or liquid is made of a phenyl siloxane having different diphenyl or phenyl content. In a preferred embodiment, the lens chamber walls have a diphenyl or phenyl content that is less than that for the gel or liquid. In another preferred embodiment, the walls of the lens chamber may be made of a cross-linked vinyl-terminated phenyl siloxane having a diphenyl content of about 15-18 mol % or a phenyl content of about 30-36 mol % and the gel contained within the lens chamber walls may be made of a vinyl-terminated phenyl-siloxane having a diphenyl content of 20-25 mol % or a phenyl content of 30-36 mol %.
In another embodiment, the differential refractive indices may be provided by providing a dimethyl siloxane for the lens chamber walls and the gel may be a phenyl siloxane having a high diphenyl or phenyl content. In a preferred embodiment, the diphenyl content is at last 20 mol %, at least 25 mol %, at least 30 mol %, at least 35 mol %, and at least 40 mol %. Alternatively, the phenyl content is at least 40 mol %, at least 50 mol %, at least 60 mol %, at least 70 mol % and at least 80 mol %.
In a further embodiment, the differential refractive indices may be provided by a crosslinked fluoro siloxane, such as a 3,3,3-trifluoropropylmethyl siloxane and the gel may be a phenyl siloxane having a high diphenyl or phenyl content. In a preferred embodiment, the diphenyl content is at least 20 mol %, at least 25 mol %, at least 30 mol %, at least 35 mol %, and at least 40 mol %. Alternatively, the phenyl content is at least 40 mol %, at least 50 mol %, at least 60 mol %, at least 70 mol %, and at least 80 mol %.
In each of these embodiments, certain features remain the same. The power changing lens 210 is depicted as comprising a fluid- or gel-filled lens chamber 212 and a haptic system 214 disposed peripherally of the fluid- or gel-filled lens chamber 212. The lens chamber 212 comprises two opposing surfaces which are divided into a central regions 212a, 212b about the central axis A-A (See
In a preferred embodiment, the center point of the central regions 212a, 212b has a thickness that is two times or more, preferably three times or more, and most preferably 4 times or more than the thickness of the peripheral region 211a, 211b. A fluid or gel 213 is contained between the opposing surfaces. In another preferred embodiment, the point of greatest thickness in the central region 212a, 212b and the point of least thickness in the peripheral region 211a, 211b is a ratio of 2:1 or greater, preferably 3:1 or greater, and most preferably 4:1 or greater. In a preferred embodiment, the thickness at the optical axis or the center of the central region 212a, 212b is about 200 microns and the thickness at the peripheral region 211a, 211b is about 50 microns. The increased thickness in the central region 212a, 212b is provided so as to prevent the opposing surfaces of the lens chamber 212 from buckling when it is deformed in response to accommodation. It is understood that in the various embodiments of the power lens depicted in the figures, the opposing sides preferably has the thickness profiles as described herein and depicted in
The opposing surfaces of the lens chamber 212 actuate towards and away from each other when the eye is unaccommodated and accommodated, respectively. The haptic system 214 comprises a peripheral engaging edge 216 and a first coupling surface 218 adjacent the peripheral engaging edge 216. The primary lens assembly 230 comprises a fixed lens 232 and a plurality of centration members 224 disposed about the fixed lens 232. The centration members 224 comprise a distal edge 236 and a second contacting surfaces 238 in sliding contact with the first contacting surfaces 218 of the power changing lens 210.
In a preferred embodiment, the primary lens 230 is substantially thicker than one of the opposing sides lens chamber 212, as measured along the optical axis A-A. In a preferred embodiment, the thickness of each one of the opposing sides lens chamber 212, as along the optical axis A-A is less than ½, preferably less than ⅓, preferably less than ¼, and most preferably less than ⅕ of the thickness of the primary lens 230 at the central optical axis A-A. Because the primary lens 230 is substantially thicker than either one of the opposing sides lens chamber 212, the primary lens 230 has an effective Young's modulus that is substantially greater than either one of the opposing sides of the chamber 212.
Turning now to the various distinguishing features of the two-part IOL devices, reference is made with respect to
The fixed lens assembly 350 is configured to house and receive the power changing lens 310. The fixed lens assembly 350 comprises a fixed lens 352 centrally disposed and an internal cavity defined by the fixed lens 352, the peripheral side wall 356 and a plurality of radial protrusions 358 projecting inwardly from the top of the peripheral side wall 356. Circumferential grooves or hinges 354 surround the fixed lens 352 and permit pivoting or compression of the peripheral side wall 356 radially inward. A plurality of circumferential holes 359 are provided about the periphery of the fixed lens 352 to permit the flow of aqueous fluid therethrough and into the cavity 375 (
The implantation and assembly of the two-part IOL device 300 follows two steps. In a first step, the fixed lens assembly 350 is inserted into the capsular bag of the eye following capsulhorexis. The fixed lens assembly 350 is centered such that the peripheral side wall 356 engages the circumferential area of the capsular bag that is most densely connected to the zonules and the fixed lens 352 is centered about the optical axis and is in contact with the posterior portion of the capsular bag. In a second step, the power changing lens 310 is inserted into the capsular bag and positioned within the cavity 375 of the fixed lens assembly 350 such that the peripheral engaging edge 316 is in proximity to or in contact with the inner surface 360 of the peripheral side wall 356. Thus, radial compression applied to the peripheral side wall 356 is transmitted to the peripheral engaging edge 316 of the power changing lens 310 such that the fluid- or gel-filled lens increases and decreases in curvature to provide an accommodating response to the relaxation and contraction of the ciliary muscles of the eye, respectively.
Additionally the IOL devices 400A, 400B are provided with curved surfaces at the points of contact between the power changing lens 410 and the fixed lens assembly 450 to facilitate a sliding movement between them. Thus, in a preferred embodiment, at least the circumferential periphery 456, the engaging edge 416 and the inner surface 460 of the circumferential periphery 456 are curved surfaces.
The two opposing surfaces are divided into central regions 512a, 512b and peripheral regions 511a, 511b. In a preferred embodiment, the central regions 512a, 512b have a gradually increasing thickness radially towards the center of the enclosed lens chamber 512 from the peripheral regions 511a, 511b. In a preferred embodiment, the center point of the central regions 512a, 512b has a thickness that is two times or more, preferably three times or more, and most preferably 4 times or more than the thickness of the peripheral region 511a, 511b. A fluid or gel 213 is contained between the opposing surfaces. In another preferred embodiment, the point of greatest thickness in the central region 512a, 512b and the point of least thickness in the peripheral region 511a, 511b is a ratio of 2:1 or greater, preferably 3:1 or greater, and most preferably 4:1 or greater. In a preferred embodiment, the thickness at the optical axis or the center of the central region 512a, 512b is about 200 microns and the thickness at the peripheral region 511a, 511b is about 50 microns. The increased thickness in the central region 512a, 512b is provided so as to prevent the opposing surfaces of the enclosed lens chamber 512 from buckling when it is deformed in response to accommodation. It is understood that in the various embodiments of the power lens depicted in the figures, the opposing sides preferably has the thickness profiles as described herein and depicted in
The fixed-lens assembly 550 comprises a fixed lens 552 that does not change in shape or curvature. An internal cavity is defined by the fixed lens 552 and the circumferential side walls 560. A circumferential hinge 554 provided on the fixed-lens assembly 550 peripherally of the fixed lens 552. The hinge 554 is disposed around the fixed lens 554 and thus permits the peripheral side wall 556 to be compressed radially-inwards in the direction of the arrows B to compress the power changing lens 510 at the contacting periphery 516. This, in turn, causes the opposing sides 512a, 512b to curve away from one another. Once the radial forces are no longer applied, the fixed lens assembly is resiliently biased to the expanded and unaccommodated state and the peripheral side wall expands in the direction as indicated by the arrows A.
The invention described and claimed herein is not to be limited in scope by the specific preferred embodiments disclosed herein, as these embodiments are intended as illustrations of several aspects of the invention. Indeed, various modifications of the invention in addition to those shown and described herein will become apparent to those skilled in the art from the foregoing description. Such modifications are also intended to fall within the scope of the appended claims.
This application is a continuation of U.S. Ser. No. 16/207,658, filed Dec. 3, 2018, which is a continuation of U.S. Ser. No. 15/144,544, now U.S. Pat. No. 10,159,564, filed May 2, 2016, which is a continuation of International Patent Application No. PCT/US2014/063538 filed Oct. 31, 2014, which claims the benefit of Provisional Patent Application No. 61/899,110 filed Nov. 1, 2013, both of which are incorporated herein by reference in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
4032502 | Lee et al. | Jun 1977 | A |
4073014 | Poler | Feb 1978 | A |
4118808 | Poler | Oct 1978 | A |
4373218 | Schachar | Feb 1983 | A |
4512040 | McClure | Apr 1985 | A |
4585457 | Kalb | Apr 1986 | A |
4676791 | LeMaster et al. | Jun 1987 | A |
4720286 | Bailey et al. | Jan 1988 | A |
4731078 | Stoy et al. | Mar 1988 | A |
4822360 | Deacon | Apr 1989 | A |
4842601 | Smith | Jun 1989 | A |
4882368 | Elias et al. | Nov 1989 | A |
4888012 | Horn et al. | Dec 1989 | A |
4892543 | Turley | Jan 1990 | A |
4932966 | Christie et al. | Jul 1990 | A |
5035710 | Nakada et al. | Jul 1991 | A |
5059668 | Fukuda et al. | Oct 1991 | A |
5074876 | Kelman | Dec 1991 | A |
5091121 | Nakada et al. | Feb 1992 | A |
5152788 | Isaacson et al. | Oct 1992 | A |
5167883 | Takemasa et al. | Dec 1992 | A |
5171773 | Chaffe et al. | Dec 1992 | A |
5227447 | Sato et al. | Jul 1993 | A |
5236970 | Christ et al. | Aug 1993 | A |
5264522 | Mize et al. | Nov 1993 | A |
5275623 | Sarfarazi | Jan 1994 | A |
5278258 | Gerace et al. | Jan 1994 | A |
5312860 | Mize et al. | May 1994 | A |
5326506 | Vanderbilt | Jul 1994 | A |
5336487 | Refojo et al. | Aug 1994 | A |
5443506 | Garabet | Aug 1995 | A |
5447987 | Sato et al. | Sep 1995 | A |
5489302 | Skottun | Feb 1996 | A |
5583178 | Oxman et al. | Dec 1996 | A |
5607472 | Thompson | Mar 1997 | A |
5665794 | Maxson et al. | Sep 1997 | A |
5854310 | Maxson | Dec 1998 | A |
6071439 | Bawa et al. | Jun 2000 | A |
6117171 | Skottun | Sep 2000 | A |
6197057 | Peyman et al. | Mar 2001 | B1 |
6200342 | Tassignon | Mar 2001 | B1 |
6200581 | Lin et al. | Mar 2001 | B1 |
6201091 | Halloran et al. | Mar 2001 | B1 |
6361561 | Huo et al. | Mar 2002 | B1 |
6551354 | Ghazizadeh et al. | Apr 2003 | B1 |
6616691 | Tran | Sep 2003 | B1 |
6695881 | Peng et al. | Feb 2004 | B2 |
6730123 | Klopotek | May 2004 | B1 |
6797004 | Brady et al. | Sep 2004 | B1 |
6836374 | Esch et al. | Dec 2004 | B2 |
6855164 | Glazier | Feb 2005 | B2 |
6858040 | Nguyen et al. | Feb 2005 | B2 |
6860601 | Shadduck | Mar 2005 | B2 |
6881225 | Okada | Apr 2005 | B2 |
6926736 | Peng et al. | Aug 2005 | B2 |
6930838 | Schachar | Aug 2005 | B2 |
6935743 | Shadduck | Aug 2005 | B2 |
6966649 | Shadduck | Nov 2005 | B2 |
6969403 | Peng et al. | Nov 2005 | B2 |
6991651 | Portney | Jan 2006 | B2 |
7041134 | Nguyen et al. | May 2006 | B2 |
7063723 | Ran | Jun 2006 | B2 |
7068439 | Esch et al. | Jun 2006 | B2 |
7122053 | Esch | Oct 2006 | B2 |
7150760 | Zhang | Dec 2006 | B2 |
7217288 | Esch et al. | May 2007 | B2 |
7220279 | Nun | May 2007 | B2 |
7223288 | Zhang et al. | May 2007 | B2 |
7226478 | Ting et al. | Jun 2007 | B2 |
7229475 | Glazier | Jun 2007 | B2 |
7238201 | Portney et al. | Jul 2007 | B2 |
7247168 | Esch et al. | Jul 2007 | B2 |
7261737 | Esch et al. | Aug 2007 | B2 |
7264351 | Shadduck | Sep 2007 | B2 |
7276619 | Kunzler et al. | Oct 2007 | B2 |
7278739 | Shadduck | Oct 2007 | B2 |
7316713 | Zhang | Jan 2008 | B2 |
7416562 | Gross | Aug 2008 | B2 |
7438723 | Esch | Oct 2008 | B2 |
7452377 | Watling et al. | Nov 2008 | B2 |
7453646 | Lo | Nov 2008 | B2 |
7455691 | Feingold et al. | Nov 2008 | B2 |
7485144 | Esch | Feb 2009 | B2 |
7591849 | Richardson | Sep 2009 | B2 |
7637947 | Smith et al. | Dec 2009 | B2 |
7662179 | Sarfarazi | Feb 2010 | B2 |
7675686 | Lo et al. | Mar 2010 | B2 |
7753953 | Yee | Jul 2010 | B1 |
7776088 | Shadduck | Aug 2010 | B2 |
7780729 | Nguyen et al. | Aug 2010 | B2 |
7815678 | Nun | Oct 2010 | B2 |
7842087 | Nun | Nov 2010 | B2 |
7854764 | Nun | Dec 2010 | B2 |
7857850 | Mentak et al. | Dec 2010 | B2 |
7918886 | Aharoni et al. | Apr 2011 | B2 |
7981155 | Cumming | Jul 2011 | B2 |
7985253 | Cumming | Jul 2011 | B2 |
7986465 | Lo et al. | Jul 2011 | B1 |
7998198 | Angelopoulos et al. | Aug 2011 | B2 |
7998199 | Nun | Aug 2011 | B2 |
8012204 | Weinschenk, III et al. | Sep 2011 | B2 |
8018658 | Lo | Sep 2011 | B2 |
8034106 | Mentak et al. | Oct 2011 | B2 |
8034107 | Stenger | Oct 2011 | B2 |
8038711 | Clarke | Oct 2011 | B2 |
8048155 | Shadduck | Nov 2011 | B2 |
8052752 | Woods et al. | Nov 2011 | B2 |
8062361 | Nguyen et al. | Nov 2011 | B2 |
8066768 | Werblin | Nov 2011 | B2 |
8066769 | Werblin | Nov 2011 | B2 |
8070806 | Khoury | Dec 2011 | B2 |
8158712 | Your | Apr 2012 | B2 |
8182531 | Hermans et al. | May 2012 | B2 |
8187325 | Zadno-Azizi et al. | May 2012 | B2 |
8197541 | Schedler | Jun 2012 | B2 |
8216306 | Coroneo | Jul 2012 | B2 |
8246679 | Nguyen et al. | Aug 2012 | B2 |
8254034 | Shields et al. | Aug 2012 | B1 |
8257827 | Shi et al. | Sep 2012 | B1 |
8273123 | Nun | Sep 2012 | B2 |
8303656 | Shadduck | Nov 2012 | B2 |
8308800 | Chu | Nov 2012 | B2 |
8314927 | Choi et al. | Nov 2012 | B2 |
8320049 | Huang et al. | Nov 2012 | B2 |
8328869 | Smiley et al. | Dec 2012 | B2 |
8361145 | Scholl et al. | Jan 2013 | B2 |
8377124 | Hong et al. | Feb 2013 | B2 |
8377125 | Kellan | Feb 2013 | B2 |
8398709 | Nun | Mar 2013 | B2 |
8414646 | De Juan, Jr. et al. | Apr 2013 | B2 |
8425597 | Glick et al. | Apr 2013 | B2 |
8425599 | Shadduck | Apr 2013 | B2 |
8430928 | Liao | Apr 2013 | B2 |
8447086 | Hildebrand et al. | May 2013 | B2 |
8454688 | Esch et al. | Jun 2013 | B2 |
8475529 | Clarke | Jul 2013 | B2 |
8491651 | Tsai et al. | Jul 2013 | B2 |
8496701 | Hermans et al. | Jul 2013 | B2 |
8500806 | Phillips | Aug 2013 | B1 |
8518026 | Culbertson et al. | Aug 2013 | B2 |
8545556 | Woods et al. | Oct 2013 | B2 |
8579972 | Rombach | Nov 2013 | B2 |
8585758 | Woods | Nov 2013 | B2 |
8603167 | Rombach | Dec 2013 | B2 |
8608799 | Blake | Dec 2013 | B2 |
8608800 | Portney | Dec 2013 | B2 |
8613766 | Richardson et al. | Dec 2013 | B2 |
8647384 | Lu | Feb 2014 | B2 |
8657810 | Culbertson et al. | Feb 2014 | B2 |
8657878 | Mentak et al. | Feb 2014 | B2 |
8668734 | Hildebrand et al. | Mar 2014 | B2 |
8690942 | Hildebrand et al. | Mar 2014 | B2 |
8715345 | DeBoer et al. | May 2014 | B2 |
8715346 | De Juan, Jr. et al. | May 2014 | B2 |
8734509 | Mentak et al. | May 2014 | B2 |
8771347 | DeBoer et al. | Jul 2014 | B2 |
8814934 | Geraghty et al. | Aug 2014 | B2 |
8834565 | Nun | Sep 2014 | B2 |
8834566 | Jones | Sep 2014 | B1 |
8858626 | Noy | Oct 2014 | B2 |
8867141 | Pugh et al. | Oct 2014 | B2 |
8900298 | Anvar et al. | Dec 2014 | B2 |
8900300 | Wortz | Dec 2014 | B1 |
8920495 | Mirlay | Dec 2014 | B2 |
8956408 | Smiley et al. | Feb 2015 | B2 |
8968396 | Matthews et al. | Mar 2015 | B2 |
8968399 | Ghabra | Mar 2015 | B2 |
8992609 | Shadduck | Mar 2015 | B2 |
9005282 | Chang et al. | Apr 2015 | B2 |
9005283 | Nguyen et al. | Apr 2015 | B2 |
9034035 | Betser et al. | May 2015 | B2 |
9044317 | Hildebrand et al. | Jun 2015 | B2 |
9072600 | Tran | Jul 2015 | B2 |
9090033 | Carson et al. | Jul 2015 | B2 |
9095424 | Kahook et al. | Aug 2015 | B2 |
9125736 | Kahook et al. | Sep 2015 | B2 |
9149356 | Sarfarazi | Oct 2015 | B2 |
9186244 | Silvestrini et al. | Nov 2015 | B2 |
9198752 | Woods | Dec 2015 | B2 |
9277987 | Smiley et al. | Mar 2016 | B2 |
9277988 | Chu | Mar 2016 | B1 |
9289287 | Kahook et al. | Mar 2016 | B2 |
9326846 | Devita Gerardi et al. | May 2016 | B2 |
9333072 | Ichikawa | May 2016 | B2 |
9358103 | Wortz et al. | Jun 2016 | B1 |
9364316 | Kahook et al. | Jun 2016 | B1 |
9387069 | Kahook et al. | Jul 2016 | B2 |
9398949 | Werblin | Jul 2016 | B2 |
9421088 | Kahook et al. | Aug 2016 | B1 |
9427312 | DeBoer et al. | Aug 2016 | B2 |
9433497 | DeBoer et al. | Sep 2016 | B2 |
9456895 | Shadduck | Oct 2016 | B2 |
9486311 | Argento et al. | Nov 2016 | B2 |
9610155 | Matthews | Apr 2017 | B2 |
9622852 | Simonov et al. | Apr 2017 | B2 |
9629712 | Stenger | Apr 2017 | B2 |
9636213 | Brady | May 2017 | B2 |
9655716 | Cumming | May 2017 | B2 |
9681946 | Kahook et al. | Jun 2017 | B2 |
9693858 | Hildebrand et al. | Jul 2017 | B2 |
9713526 | Rombach | Jul 2017 | B2 |
9713527 | Nishi et al. | Jul 2017 | B2 |
9717589 | Simonov et al. | Aug 2017 | B2 |
9744027 | Jansen | Aug 2017 | B2 |
9744028 | Simonov et al. | Aug 2017 | B2 |
9795472 | Culbertson et al. | Oct 2017 | B2 |
9795473 | Smiley et al. | Oct 2017 | B2 |
9808339 | Dorronsoro Diaz et al. | Nov 2017 | B2 |
9814568 | Ben Nun | Nov 2017 | B2 |
9814570 | Robert et al. | Nov 2017 | B2 |
9820849 | Jansen | Nov 2017 | B2 |
9848980 | McCafferty | Dec 2017 | B2 |
9855137 | Smiley et al. | Jan 2018 | B2 |
9855139 | Matthews et al. | Jan 2018 | B2 |
9861469 | Simonov et al. | Jan 2018 | B2 |
9872762 | Scholl et al. | Jan 2018 | B2 |
9872763 | Smiley et al. | Jan 2018 | B2 |
9877825 | Kahook et al. | Jan 2018 | B2 |
9883940 | Nishi et al. | Feb 2018 | B2 |
9925039 | Sohn et al. | Mar 2018 | B2 |
9925040 | Kahook et al. | Mar 2018 | B2 |
9931202 | Borja et al. | Apr 2018 | B2 |
9987126 | Borja et al. | Jun 2018 | B2 |
10004596 | Brady et al. | Jun 2018 | B2 |
10010405 | Hayes | Jul 2018 | B2 |
10028824 | Kahook et al. | Jul 2018 | B2 |
10039635 | Wanders | Aug 2018 | B2 |
10045844 | Smiley et al. | Aug 2018 | B2 |
10080648 | Kahook et al. | Sep 2018 | B2 |
10080649 | Zhang et al. | Sep 2018 | B2 |
10111745 | Silvestrini et al. | Oct 2018 | B2 |
10159562 | Cady | Dec 2018 | B2 |
10159564 | Brady et al. | Dec 2018 | B2 |
10195017 | Culbertson et al. | Feb 2019 | B2 |
10195018 | Salahieh et al. | Feb 2019 | B2 |
10195020 | Matthews | Feb 2019 | B2 |
10285805 | De Juan, Jr. et al. | May 2019 | B2 |
10299910 | Cady | May 2019 | B2 |
10299913 | Smiley et al. | May 2019 | B2 |
10327886 | Sohn et al. | Jun 2019 | B2 |
10350056 | Argento et al. | Jul 2019 | B2 |
10363129 | Ghabra et al. | Jul 2019 | B2 |
10368979 | Scholl et al. | Aug 2019 | B2 |
10390937 | Smiley et al. | Aug 2019 | B2 |
10433949 | Smiley et al. | Oct 2019 | B2 |
10463473 | Rombach et al. | Nov 2019 | B2 |
10485654 | Brady et al. | Nov 2019 | B2 |
10526353 | Silvestrini | Jan 2020 | B2 |
10548719 | Pallikaris et al. | Feb 2020 | B2 |
10647831 | Silvestrini et al. | May 2020 | B2 |
10772721 | Rao et al. | Sep 2020 | B2 |
10842614 | Cady | Nov 2020 | B2 |
10842616 | Silvestrini et al. | Nov 2020 | B2 |
10888219 | Smith et al. | Jan 2021 | B2 |
10905547 | Auld et al. | Feb 2021 | B2 |
10912676 | Schaller et al. | Feb 2021 | B2 |
10917543 | Luna et al. | Feb 2021 | B2 |
10945832 | Cady | Mar 2021 | B2 |
10959836 | Qureshi et al. | Mar 2021 | B2 |
10980629 | Anvar et al. | Apr 2021 | B2 |
10987183 | Brennan et al. | Apr 2021 | B2 |
11000363 | Campin et al. | May 2021 | B2 |
11000367 | Wu et al. | May 2021 | B2 |
11026838 | Raksi | Jun 2021 | B2 |
11039901 | Tripathi | Jun 2021 | B2 |
11040477 | Chauvin et al. | Jun 2021 | B2 |
11045309 | Kahook et al. | Jun 2021 | B2 |
11046490 | Cerveny | Jun 2021 | B2 |
11051884 | Tripathi et al. | Jul 2021 | B2 |
11065107 | Brady et al. | Jul 2021 | B2 |
11065109 | Argento et al. | Jul 2021 | B2 |
11065152 | Kelleher et al. | Jul 2021 | B2 |
11071449 | Heeren | Jul 2021 | B2 |
11071622 | Matthews | Jul 2021 | B2 |
11076948 | Kahook et al. | Aug 2021 | B2 |
11083567 | Honigsbaum | Aug 2021 | B2 |
11109957 | Cady | Sep 2021 | B2 |
11109960 | Borja et al. | Sep 2021 | B2 |
11110005 | Diao et al. | Sep 2021 | B2 |
11111055 | Reece et al. | Sep 2021 | B2 |
11141263 | Argento et al. | Oct 2021 | B2 |
11162065 | Fachin et al. | Nov 2021 | B2 |
11166808 | Smiley et al. | Nov 2021 | B2 |
11166844 | Charles | Nov 2021 | B2 |
11173008 | Mirsepassi et al. | Nov 2021 | B2 |
11213606 | Jiang et al. | Jan 2022 | B2 |
11224540 | Sivadas | Jan 2022 | B2 |
11298221 | McCulloch | Apr 2022 | B2 |
20020005344 | Heidlas et al. | Jan 2002 | A1 |
20020055776 | Juan, Jr. et al. | May 2002 | A1 |
20020071856 | Dillingham et al. | Jun 2002 | A1 |
20020120329 | Lang et al. | Aug 2002 | A1 |
20020138140 | Hanna | Sep 2002 | A1 |
20030060881 | Glick et al. | Mar 2003 | A1 |
20030093149 | Glazier | May 2003 | A1 |
20030105522 | Glazier | Jun 2003 | A1 |
20030109926 | Portney | Jun 2003 | A1 |
20030149480 | Shadduck | Aug 2003 | A1 |
20030158295 | Fukuda et al. | Aug 2003 | A1 |
20030204254 | Peng et al. | Oct 2003 | A1 |
20030204256 | Peng et al. | Oct 2003 | A1 |
20040015236 | Sarfarazi | Jan 2004 | A1 |
20040082993 | Woods | Apr 2004 | A1 |
20040082994 | Woods et al. | Apr 2004 | A1 |
20040111152 | Kelman | Jun 2004 | A1 |
20040148023 | Shu | Jul 2004 | A1 |
20040162612 | Portney et al. | Aug 2004 | A1 |
20040169816 | Esch | Sep 2004 | A1 |
20040169932 | Esch et al. | Sep 2004 | A1 |
20040249455 | Tran | Dec 2004 | A1 |
20050021139 | Shadduck | Jan 2005 | A1 |
20050071002 | Glazier | Mar 2005 | A1 |
20050107873 | Zhou | May 2005 | A1 |
20050119740 | Esch et al. | Jun 2005 | A1 |
20050137703 | Chen | Jun 2005 | A1 |
20050149183 | Shadduck | Jul 2005 | A1 |
20050251253 | Gross | Nov 2005 | A1 |
20050251254 | Brady et al. | Nov 2005 | A1 |
20050267575 | Nguyen et al. | Dec 2005 | A1 |
20060041307 | Esch et al. | Feb 2006 | A1 |
20060047339 | Brown | Mar 2006 | A1 |
20060069178 | Rastogi et al. | Mar 2006 | A1 |
20060074487 | Gilg | Apr 2006 | A1 |
20060100701 | Esch et al. | May 2006 | A1 |
20060111776 | Glick et al. | May 2006 | A1 |
20060134173 | Liu et al. | Jun 2006 | A1 |
20060135477 | Haitjema et al. | Jun 2006 | A1 |
20060212116 | Woods | Sep 2006 | A1 |
20060238702 | Glick et al. | Oct 2006 | A1 |
20060241752 | Israel | Oct 2006 | A1 |
20060271186 | Nishi et al. | Nov 2006 | A1 |
20070016293 | Tran | Jan 2007 | A1 |
20070032868 | Woods | Feb 2007 | A1 |
20070050024 | Zhang | Mar 2007 | A1 |
20070050025 | Nguyen et al. | Mar 2007 | A1 |
20070078515 | Brady et al. | Apr 2007 | A1 |
20070088433 | Esch et al. | Apr 2007 | A1 |
20070100445 | Shadduck | May 2007 | A1 |
20070106377 | Smith et al. | May 2007 | A1 |
20070118216 | Pynson | May 2007 | A1 |
20070129798 | Chawdhary | Jun 2007 | A1 |
20070129799 | Schedler | Jun 2007 | A1 |
20070129800 | Cumming | Jun 2007 | A1 |
20070129801 | Cumming | Jun 2007 | A1 |
20070132949 | Phelan | Jun 2007 | A1 |
20070156236 | Stenger | Jul 2007 | A1 |
20070213817 | Esch et al. | Sep 2007 | A1 |
20070260308 | Tran | Nov 2007 | A1 |
20070260310 | Richardson | Nov 2007 | A1 |
20080015689 | Esch et al. | Jan 2008 | A1 |
20080033547 | Chang et al. | Feb 2008 | A1 |
20080046074 | Smith et al. | Feb 2008 | A1 |
20080046075 | Esch et al. | Feb 2008 | A1 |
20080046077 | Cumming | Feb 2008 | A1 |
20080051886 | Lin | Feb 2008 | A1 |
20080154364 | Richardson et al. | Jun 2008 | A1 |
20080200982 | Your | Aug 2008 | A1 |
20080269887 | Cumming | Oct 2008 | A1 |
20080300680 | Nun | Dec 2008 | A1 |
20080306587 | Your | Dec 2008 | A1 |
20080306588 | Smiley | Dec 2008 | A1 |
20080306589 | Donitzky et al. | Dec 2008 | A1 |
20090005865 | Smiley et al. | Jan 2009 | A1 |
20090027661 | Choi et al. | Jan 2009 | A1 |
20090043384 | Niwa et al. | Feb 2009 | A1 |
20090116118 | Frazier et al. | May 2009 | A1 |
20090125106 | Weinschenk, III et al. | May 2009 | A1 |
20090149952 | Shadduck | Jun 2009 | A1 |
20090198326 | Zhou et al. | Aug 2009 | A1 |
20090204209 | Tran | Aug 2009 | A1 |
20090204210 | Pynson | Aug 2009 | A1 |
20090264998 | Mentak et al. | Oct 2009 | A1 |
20090292355 | Boyd et al. | Nov 2009 | A1 |
20090319040 | Khoury | Dec 2009 | A1 |
20100004742 | Cumming | Jan 2010 | A1 |
20100055449 | Ota | Mar 2010 | A1 |
20100057095 | Khuray et al. | Mar 2010 | A1 |
20100094412 | Wensrich | Apr 2010 | A1 |
20100094413 | Rombach et al. | Apr 2010 | A1 |
20100131058 | Shadduck | May 2010 | A1 |
20100131059 | Callahan et al. | May 2010 | A1 |
20100179653 | Argento et al. | Jul 2010 | A1 |
20100204787 | Noy | Aug 2010 | A1 |
20100211169 | Stanley et al. | Aug 2010 | A1 |
20100228344 | Shadduck | Sep 2010 | A1 |
20100288346 | Esch | Sep 2010 | A1 |
20100324672 | Esch et al. | Dec 2010 | A1 |
20100324674 | Brown | Dec 2010 | A1 |
20110029074 | Reisin et al. | Feb 2011 | A1 |
20110071628 | Gross et al. | Mar 2011 | A1 |
20110118834 | Lo et al. | May 2011 | A1 |
20110118836 | Jain | May 2011 | A1 |
20110208301 | Anvar et al. | Aug 2011 | A1 |
20110224788 | Webb | Sep 2011 | A1 |
20110264209 | Wiechmann et al. | Oct 2011 | A1 |
20110282442 | Scholl et al. | Nov 2011 | A1 |
20110288638 | Smiley et al. | Nov 2011 | A1 |
20120016473 | Brady et al. | Jan 2012 | A1 |
20120035724 | Clarke | Feb 2012 | A1 |
20120071972 | Zhao | Mar 2012 | A1 |
20120078364 | Stenger | Mar 2012 | A1 |
20120095125 | Hu et al. | Apr 2012 | A1 |
20120150292 | Mentak et al. | Jun 2012 | A1 |
20120232649 | Cuevas | Sep 2012 | A1 |
20120245683 | Christie et al. | Sep 2012 | A1 |
20120253458 | Geraghty et al. | Oct 2012 | A1 |
20120253459 | Reich et al. | Oct 2012 | A1 |
20120290084 | Coroneo | Nov 2012 | A1 |
20120296423 | Caffey | Nov 2012 | A1 |
20120296424 | Betser | Nov 2012 | A1 |
20120310341 | Simonov et al. | Dec 2012 | A1 |
20120310343 | Van Noy | Dec 2012 | A1 |
20130006353 | Betser et al. | Jan 2013 | A1 |
20130035760 | Portney | Feb 2013 | A1 |
20130038944 | Chang et al. | Feb 2013 | A1 |
20130040073 | Pett et al. | Feb 2013 | A1 |
20130060331 | Shadduck | Mar 2013 | A1 |
20130110234 | DeVita et al. | May 2013 | A1 |
20130110235 | Shweigerling | May 2013 | A1 |
20130116781 | Nun | May 2013 | A1 |
20130131794 | Smiley et al. | May 2013 | A1 |
20130190867 | Peyman | Jul 2013 | A1 |
20130231741 | Clarke | Sep 2013 | A1 |
20130250239 | Hildebrand et al. | Sep 2013 | A1 |
20130268070 | Esch et al. | Oct 2013 | A1 |
20130297018 | Brady et al. | Nov 2013 | A1 |
20130317607 | DeBoer et al. | Nov 2013 | A1 |
20130317608 | Hermans et al. | Nov 2013 | A1 |
20140012277 | Matthews et al. | Jan 2014 | A1 |
20140058507 | Reich et al. | Feb 2014 | A1 |
20140085726 | Portney | Mar 2014 | A1 |
20140100654 | Portney et al. | Apr 2014 | A1 |
20140107459 | Lind et al. | Apr 2014 | A1 |
20140111765 | DeBoer et al. | Apr 2014 | A1 |
20140121768 | Simpson | May 2014 | A1 |
20140135917 | Glazier | May 2014 | A1 |
20140135918 | De Juan, Jr. et al. | May 2014 | A1 |
20140142558 | Culbertson et al. | May 2014 | A1 |
20140172089 | Lee et al. | Jun 2014 | A1 |
20140172092 | Carson et al. | Jun 2014 | A1 |
20140180403 | Silvestrini et al. | Jun 2014 | A1 |
20140180404 | Tram | Jun 2014 | A1 |
20140180405 | Weinschenk, III et al. | Jun 2014 | A1 |
20140180406 | Simpson | Jun 2014 | A1 |
20140180407 | Sohn et al. | Jun 2014 | A1 |
20140180410 | Gerardi | Jun 2014 | A1 |
20140227437 | DeBoer et al. | Aug 2014 | A1 |
20140228949 | Argento et al. | Aug 2014 | A1 |
20140249625 | Shadduck | Sep 2014 | A1 |
20140257478 | McCafferty | Sep 2014 | A1 |
20140257479 | McCafferty | Sep 2014 | A1 |
20140296977 | Culbertson et al. | Oct 2014 | A1 |
20140309734 | Sohn et al. | Oct 2014 | A1 |
20150087743 | Anvar et al. | Mar 2015 | A1 |
20150105760 | Rao et al. | Apr 2015 | A1 |
20150127102 | Wortz | May 2015 | A1 |
20150173892 | Borja et al. | Jun 2015 | A1 |
20150202041 | Shadduck | Jul 2015 | A1 |
20150216652 | Jansen | Aug 2015 | A1 |
20150230980 | Culbertson et al. | Aug 2015 | A1 |
20150238310 | Matthews et al. | Aug 2015 | A1 |
20150327991 | Hayes | Nov 2015 | A1 |
20150342728 | Simonov et al. | Dec 2015 | A1 |
20150359625 | Argal et al. | Dec 2015 | A1 |
20150366656 | Wortz et al. | Dec 2015 | A1 |
20160000558 | Honigsbaum | Jan 2016 | A1 |
20160008126 | Salahieh et al. | Jan 2016 | A1 |
20160051361 | Phillips | Feb 2016 | A1 |
20160058553 | Salahieh et al. | Mar 2016 | A1 |
20160074154 | Woods | Mar 2016 | A1 |
20160106534 | Deboer et al. | Apr 2016 | A1 |
20160113761 | Nishi et al. | Apr 2016 | A1 |
20160128826 | Silvestrini et al. | May 2016 | A1 |
20160184089 | Dudee et al. | Jun 2016 | A1 |
20160184092 | Smiley et al. | Jun 2016 | A1 |
20160208138 | Nishijima et al. | Jul 2016 | A1 |
20160256265 | Borja et al. | Sep 2016 | A1 |
20160262875 | Smith et al. | Sep 2016 | A1 |
20160281019 | Deklippel et al. | Sep 2016 | A1 |
20160287380 | Shi et al. | Oct 2016 | A1 |
20160317287 | Silvestrini et al. | Nov 2016 | A1 |
20160361157 | Honigsbaum | Dec 2016 | A1 |
20170020662 | Shadduck | Jan 2017 | A1 |
20170049561 | Smiley et al. | Feb 2017 | A1 |
20170049562 | Argento et al. | Feb 2017 | A1 |
20170100234 | Culbertson et al. | Apr 2017 | A1 |
20170216021 | Brady | Aug 2017 | A1 |
20170247525 | Silvestrini et al. | Aug 2017 | A1 |
20170290658 | Hildebrand et al. | Oct 2017 | A1 |
20170319332 | Kahook et al. | Nov 2017 | A1 |
20170348095 | Wortz et al. | Dec 2017 | A1 |
20180014928 | Kahook et al. | Jan 2018 | A1 |
20180028308 | Smiley et al. | Feb 2018 | A1 |
20180085211 | Culbertson et al. | Mar 2018 | A1 |
20180110613 | Wortz et al. | Apr 2018 | A1 |
20180125640 | Smiley et al. | May 2018 | A1 |
20180132997 | Smiley et al. | May 2018 | A1 |
20180147051 | Scholl et al. | May 2018 | A1 |
20180153682 | Hajela et al. | Jun 2018 | A1 |
20180161152 | Argento et al. | Jun 2018 | A1 |
20180161153 | Kahook et al. | Jun 2018 | A1 |
20180177589 | Argento et al. | Jun 2018 | A1 |
20180177639 | Rao et al. | Jun 2018 | A1 |
20180185139 | Sohn et al. | Jul 2018 | A1 |
20180256315 | Hildebrand et al. | Sep 2018 | A1 |
20180271642 | Wortz et al. | Sep 2018 | A1 |
20180271645 | Brady et al. | Sep 2018 | A1 |
20180280135 | Otts | Oct 2018 | A1 |
20180296323 | Olcina Portilla | Oct 2018 | A1 |
20180307061 | State et al. | Oct 2018 | A1 |
20180318068 | Otts et al. | Nov 2018 | A1 |
20180344453 | Brady | Dec 2018 | A1 |
20180360659 | Culbertson et al. | Dec 2018 | A1 |
20180368971 | Zacher et al. | Dec 2018 | A1 |
20180368973 | Wortz et al. | Dec 2018 | A1 |
20180368974 | Kahook et al. | Dec 2018 | A1 |
20190000612 | Rao et al. | Jan 2019 | A1 |
20190015198 | Kuiper | Jan 2019 | A1 |
20190021848 | Kahook et al. | Jan 2019 | A1 |
20190069989 | Otts et al. | Mar 2019 | A1 |
20190076239 | Wortz et al. | Mar 2019 | A1 |
20190076241 | Alarcon Heredia et al. | Mar 2019 | A1 |
20190076243 | Hadba et al. | Mar 2019 | A1 |
20190083235 | Wortz | Mar 2019 | A1 |
20190099263 | Brady et al. | Apr 2019 | A1 |
20190269499 | Ellis | Sep 2019 | A1 |
20190269500 | De Juan, Jr. et al. | Sep 2019 | A1 |
20190274823 | Argento et al. | Sep 2019 | A1 |
20190358025 | Smiley et al. | Nov 2019 | A1 |
20190374333 | Shadduck | Dec 2019 | A1 |
20190374334 | Brady et al. | Dec 2019 | A1 |
20200000577 | Smiley et al. | Jan 2020 | A1 |
20200054445 | Rosen et al. | Feb 2020 | A1 |
20200129287 | Culbertson et al. | Apr 2020 | A1 |
20200138564 | Culbertson et al. | May 2020 | A1 |
20200157124 | Silvestrini | May 2020 | A1 |
20200179104 | Brady et al. | Jun 2020 | A1 |
20200261217 | Dudee | Aug 2020 | A1 |
20200337833 | Green | Oct 2020 | A1 |
20200345481 | Ellis | Nov 2020 | A1 |
20200369853 | Silvestrini et al. | Nov 2020 | A1 |
20200397562 | Cady | Dec 2020 | A1 |
20210007554 | Byun et al. | Jan 2021 | A1 |
20210015303 | Byun et al. | Jan 2021 | A1 |
20210015359 | Goldshleger et al. | Jan 2021 | A1 |
20210030530 | Smiley et al. | Feb 2021 | A1 |
20210038373 | Collins et al. | Feb 2021 | A1 |
20210063767 | Hong et al. | Mar 2021 | A1 |
20210093447 | Heckler et al. | Apr 2021 | A1 |
20210100649 | Smiley | Apr 2021 | A1 |
20210100650 | Smiley et al. | Apr 2021 | A1 |
20210100652 | Walz et al. | Apr 2021 | A1 |
20210113327 | Auld et al. | Apr 2021 | A1 |
20210128195 | Abt | May 2021 | A1 |
20210128516 | Cheng et al. | May 2021 | A1 |
20210128800 | Chon et al. | May 2021 | A1 |
20210154957 | Olson et al. | May 2021 | A1 |
20210191153 | Borja et al. | Jun 2021 | A1 |
20210191154 | Borja et al. | Jun 2021 | A1 |
20210196890 | Appy et al. | Jul 2021 | A1 |
20210196893 | Appy et al. | Jul 2021 | A1 |
20210196894 | Appy et al. | Jul 2021 | A1 |
20210196900 | Appy et al. | Jul 2021 | A1 |
20210205134 | Rao et al. | Jul 2021 | A1 |
20210220067 | Charles | Jul 2021 | A1 |
20210228333 | Hubschman et al. | Jul 2021 | A1 |
20210244488 | Carbone et al. | Aug 2021 | A1 |
20210251718 | Tripathi | Aug 2021 | A1 |
20210259827 | Brady et al. | Aug 2021 | A1 |
20210282920 | Cady | Sep 2021 | A1 |
20210284944 | Grandhi et al. | Sep 2021 | A1 |
20210290369 | Cady | Sep 2021 | A1 |
20210290370 | Cady | Sep 2021 | A1 |
20210290371 | Anvar et al. | Sep 2021 | A1 |
20210290374 | Kahook et al. | Sep 2021 | A1 |
20210291469 | Zheng et al. | Sep 2021 | A1 |
20210292557 | Cheng et al. | Sep 2021 | A1 |
20210292558 | Bassampour et al. | Sep 2021 | A1 |
20210297560 | Luna et al. | Sep 2021 | A1 |
20210302625 | Cheng et al. | Sep 2021 | A1 |
20210315688 | Matthews | Oct 2021 | A1 |
20210322151 | Kahook et al. | Oct 2021 | A1 |
20210322219 | Raksi | Oct 2021 | A1 |
20210361415 | Borja et al. | Nov 2021 | A1 |
20210369106 | Campin et al. | Dec 2021 | A1 |
20210369446 | Taber et al. | Dec 2021 | A1 |
20210371150 | Leibold et al. | Dec 2021 | A1 |
20210401570 | Brady et al. | Dec 2021 | A1 |
20220000606 | Cady | Jan 2022 | A1 |
20220015946 | Hallen et al. | Jan 2022 | A1 |
20220047383 | Brady et al. | Feb 2022 | A1 |
Number | Date | Country |
---|---|---|
1064611 | Sep 1992 | CN |
102186438 | Sep 2011 | CN |
102271623 | Dec 2011 | CN |
20 2010 003217 | Aug 2011 | DE |
0356050 | Feb 1990 | EP |
0766540 | Aug 1999 | EP |
1 852 090 | Jan 2009 | EP |
1 859 760 | Apr 2010 | EP |
2 451 380 | Mar 2014 | EP |
2 473 137 | Mar 2014 | EP |
2 111 822 | Aug 2014 | EP |
1881818 | Jul 2015 | EP |
2 512 374 | Nov 2015 | EP |
2 501 336 | Sep 2016 | EP |
3 049 023 | Jun 2017 | EP |
3 035 889 | Feb 2019 | EP |
3 171 821 | Mar 2020 | EP |
3 463 186 | Aug 2020 | EP |
3 003 217 | Oct 2020 | EP |
3 782 584 | Feb 2021 | EP |
3 651 693 | May 2021 | EP |
3 197 396 | Sep 2021 | EP |
3 888 595 | Oct 2021 | EP |
3 932 367 | Jan 2022 | EP |
3946 155 | Feb 2022 | EP |
H09-150002 | Jun 1997 | JP |
2005-511201 | Apr 2005 | JP |
2006-511245 | Apr 2006 | JP |
2006-516002 | Jun 2006 | JP |
2007-313326 | Dec 2007 | JP |
2010-514507 | May 2010 | JP |
2011-526822 | Oct 2011 | JP |
2013-047290 | Mar 2013 | JP |
WO 9217132 | Oct 1992 | WO |
WO 9929266 | Jun 1999 | WO |
WO 1999056670 | Nov 1999 | WO |
WO 2000021467 | Apr 2000 | WO |
WO 2001034067 | May 2001 | WO |
WO 2004037127 | May 2004 | WO |
WO 2004052242 | Jun 2004 | WO |
WO 2004054471 | Jul 2004 | WO |
WO 2004072689 | Aug 2004 | WO |
WO 2006047383 | May 2006 | WO |
WO 2007005778 | Jan 2007 | WO |
WO 2007047529 | Apr 2007 | WO |
WO 2007047530 | Apr 2007 | WO |
WO 2008024766 | Feb 2008 | WO |
WO 2008031231 | Mar 2008 | WO |
WO 2008077040 | Jun 2008 | WO |
WO 2008082957 | Jul 2008 | WO |
WO 2008103798 | Aug 2008 | WO |
WO 2009015161 | Jan 2009 | WO |
WO 2009015226 | Jan 2009 | WO |
WO 2009015234 | Jan 2009 | WO |
WO 2009015240 | Jan 2009 | WO |
WO 2009064876 | May 2009 | WO |
WO 2010010565 | Jan 2010 | WO |
WO 2010081093 | Jul 2010 | WO |
WO 2011026068 | Mar 2011 | WO |
WO 2011106435 | Sep 2011 | WO |
WO 2011137191 | Nov 2011 | WO |
WO 2012006616 | Jan 2012 | WO |
WO 2012129407 | Sep 2012 | WO |
WO 2013016804 | Feb 2013 | WO |
WO 2013070924 | May 2013 | WO |
WO 2013142323 | Sep 2013 | WO |
WO 2013166068 | Nov 2013 | WO |
WO 2013180254 | Dec 2013 | WO |
WO 2013190130 | Dec 2013 | WO |
WO 2014099630 | Jun 2014 | WO |
WO 2014145562 | Sep 2014 | WO |
WO 2014152017 | Sep 2014 | WO |
WO 2014197170 | Dec 2014 | WO |
WO 2015066502 | May 2015 | WO |
WO 2015066532 | May 2015 | WO |
WO 2015126604 | Aug 2015 | WO |
WO 2015148673 | Oct 2015 | WO |
WO 2016018932 | Feb 2016 | WO |
WO 2016033217 | Mar 2016 | WO |
WO 2016049059 | Mar 2016 | WO |
WO 2016122805 | Aug 2016 | WO |
WO 2016201351 | Dec 2016 | WO |
WO 2017079449 | May 2017 | WO |
WO 2017079733 | May 2017 | WO |
WO 2017087358 | May 2017 | WO |
WO 2017096087 | Jun 2017 | WO |
WO 2017192855 | Nov 2017 | WO |
WO 2017205811 | Nov 2017 | WO |
WO 2018081595 | May 2018 | WO |
WO 2018119408 | Jun 2018 | WO |
WO 2018167099 | Sep 2018 | WO |
WO 2018222579 | Dec 2018 | WO |
WO 2018227014 | Dec 2018 | WO |
WO 2019005859 | Jan 2019 | WO |
WO 2019027845 | Feb 2019 | WO |
WO 2019089515 | May 2019 | WO |
WO 2019236908 | Dec 2019 | WO |
WO 2021092222 | May 2021 | WO |
WO 2021119174 | Jun 2021 | WO |
WO 2021126451 | Jun 2021 | WO |
Entry |
---|
Extended European Search Report and Opinion dated Jan. 20, 20157 for EP Application No. 14857916.2. (9 pages). |
International Search Report and Written Opinion dated Feb. 11, 2015 for PCT/US2014/063538. (6 pages). |
Aliancy, et al., “Long-term capsule clarity with a disk-shaped intraocular lens”, Journal of Cataract & Refractive Surgery, Apr. 2018, vol. 44, Issue 4, pp. 504-509. |
Ehrmann, et al., “Biomechanical analysis of the accommodative apparatus in primates”, Clinical and Experimental Optometry, May 2008, vol. 91, Issue 3, pp. 302-312. |
Ehrmann, et al., “Ex Vivo Accommodation Simulator II—Concept and Preliminary Results”, Proceedings of SPIE vol. 5314, Ophthalmic Technologies XIV, Jul. 2004, pp. 48-58. |
Gabel, et al., “Silicone oil with high specific gravity for intraocular use”, British Journal of Ophthalmology, Apr. 1987, vol. 71, 262-267. |
Ghallagher-Wetmore, et al., “Supercritical fluid processing: a new dry technique for photoresist developing”, SPIE's 1995 Symposium on Microlithography, 1995, vol. 2438, 16 pages. |
Kramer, et al., “Prevention of postoperative capsular bag opacification using intraocular lenses and endocapsular devices maintaining an open or expanded capsular bag”, Journal of Cataract & Refractive Surgery, Mar. 2016, vol. 42, Issue 3, pp. 469-484. |
Lane, et al., “Comparison of the biomechanical behavior of foldable intraocular lenses”, Journal of Cataract Refract Surg, Nov. 2004, vol. 30, pp. 2397-2402. |
Leishman, et al., “Prevention of capsular bag opacification with a modified hydrophilic acrylic disk-shaped intraocular lens”, Journal of Cataract & Refractive Surgery, Sep. 2012, vol. 38, Issue 9, pp. 1664-1670. |
Nakamura, et al., “Analysis and Fractionation of Silicone and Fluorosilicone Oils for Intraocular Use”, Investigative Ophthalmology & Visual Science, vol. 31, No. 10, Oct. 1990, 2059-2069. |
National Center for Biotechnology Information. PubChem Substance Database; SID=184590955, https://pubchem.ncbi.nlm.nih.gov/substance/184590955 (accessed Sep. 20, 2017). |
Zhang, et al., “Fluidic adaptive lens with high focal length tunability”, Applied Physics Letters, May 2003, vol. 82, No. 19, pp. 3171-3172. |
Zhang, et al., “Integrated fluidic adaptive zoom lens”, Optics Letters, Dec. 2004, vol. 29, No. 24, pp. 2855-2857. |
Zhao, et al., “Strategies for Supercritical CO2 Fractionation of Polydimethylsiloxane,” Journal of Applied Polymer Science, 1995, vol. 55, 773-778. |
Number | Date | Country | |
---|---|---|---|
20200085568 A1 | Mar 2020 | US |
Number | Date | Country | |
---|---|---|---|
61899110 | Nov 2013 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16207658 | Dec 2018 | US |
Child | 16694968 | US | |
Parent | 15144544 | May 2016 | US |
Child | 16207658 | US | |
Parent | PCT/US2014/063538 | Oct 2014 | US |
Child | 15144544 | US |